INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit
NCT04635878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2024-09-25
Summary
septic shock is the first cause of mortality in intensive care unit. Innate immunity is the body's first line of defense against pathogens
Conditions
Interventions
- OTHER
-
Blood collection
Blood collection (at admission, two days, one week and at discharge) to analyze the activation of NLRP3 inflammasome in platelets and leukocytes
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Fanny BOUNES, PH · University Hospital, Toulouse
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-27
- Primary Completion
- 2023-05-30
- Completion
- 2023-05-30
Countries
- France
Study Locations
More Related Trials
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227 ·Status: COMPLETED
-
Use of Fc-MBL to Detect and Monitor the Presence of PAMPs During Septic Shock
NCT03457038 ·Status: UNKNOWN ·Phase: NA
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Descriptive Study of the Evolution in Proportion of Regulatory B Lymphocytes in Patients Hospitalized in Intensive Care for Severe Sepsis
NCT03115125 ·Status: UNKNOWN ·Phase: NA
-
Study of the Role of Interferon αon the Endothelial Dysfunction During Septic Shock
NCT04204694 ·Status: UNKNOWN
-
Innate Lymphoid Cells in Septic Shock
NCT03297203 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock
NCT06853340 ·Status: RECRUITING ·Phase: NA
-
Inflammatory Mediators in Early Sepsis
NCT02692118 ·Status: UNKNOWN
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock
NCT04107402 ·Status: COMPLETED ·Phase: NA
-
Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance
NCT02391792 ·Status: UNKNOWN
-
Membrane Shedding During Septic Shock
NCT01604551 ·Status: COMPLETED
-
Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy
NCT05451537 ·Status: UNKNOWN
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Registration of Sepsis Patients in the Emergency Department
NCT06068192 ·Status: NOT_YET_RECRUITING
-
TOADS Study: TO Assess Death From Septic Shock.
NCT02547467 ·Status: UNKNOWN
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202 ·Status: COMPLETED
-
Interstitial Fluid Composition in Patients With Septic Versus Non-septic Shock: an Exploratory Pilot Study
NCT05039151 ·Status: COMPLETED